Position in CRON
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$192,705
+$190,830 QoQ
Shares Held
76,775
+10667.9% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Aquatic Capital Management LLC holds $20,937,777 across 21 Drug Manufacturers - Specialty & Generic names. CRON ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
140,331 | $5,296,091 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
97,897 | $2,948,657 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
153,759 | $2,847,616 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
198,046 | $2,742,937 | |
| 5 | ZTS |
Zoetis Inc.
|
16,038 | $1,895,851 | |
| 6 | VTRS |
Viatris Inc
|
99,833 | $1,348,743 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
6,375 | $839,842 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
141,350 | $586,602 |
All Filings in CRON
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $192,705 | 76,775 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,875 | 713 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,007 | 20,866 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $66,168 | 36,557 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $147,504 | 73,022 | Shares | Sole | 2025-02-14 | |
| 2022-09-30 | $34,968 | 12,400 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||